Skip to main content
. 2026 Sep 29;18(10):1232. doi: 10.3390/pharmaceutics18101232
AUC Area under the curve
Cmax Maximum plasma concentration
CQA Critical quality attribute
Tmax Time to maximum plasma concentration
PK Pharmacokinetics
PD Pharmacodynamics
EE Entrapment efficiency
DL Drug loading
PDI Polydispersity index
ZP Zeta potential
QbD Quality by design
GMP Good manufacturing practice
TEM Transmission electron microscopy
SEM Scanning electron microscopy
NLC Nano-lipid carrier
SLN Solid lipid nanocarrier
PC Phosphatidyl choline
RCT Randomised clinical trial
BCS Biopharmaceutical classification system